Milestones & Awards | Lee's Pharmaceutical

Awards

2022

Zhaoke Pharmaceutical (Hefei) Company Limited was honoured with the award of “2021 Anhui Provincial Role Model Enterprise in Consumer Products Industry”

2021

In-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

Honoured with “2020 Top 100 ranking of Chinese Chemical Pharmaceutical Companies” by Menet 

2019

Honoured with “Most Innovative Small and Medium-sized Pharmaceutical Enterprises Award in the Asia Pacific Region 2019” by Clarivate Analytics

Honoured with “Most Growing Award” at “China Enterprise Excellence Awards Ceremony 2019”

Honoured with “2019 China 2nd Future Unicorn Competition Top 10 in China”

2018

Honoured with “The Top 50 of Innovative Biotechnology Enterprises in Guangdong-Hong Kong-Macau Greater Bay Area”

Dr. Benjamin Li was honoured with “The 16th World Outstanding Chinese Award” by World Chinese Business Investment Foundation

2017

Honoured with “Best Listed Companies Category 2017” by Forbes

2016

Honoured with “Intellectual Technology Award” and “Recognition of Enterprise Award”

2015

Listed as “Top 42 Innovative Enterprise” in China

Honoured with “Asia’s 200 Best Under a Billion” 2015 by Forbes

Dr. Benjamin Li was honoured with “EY Entrepreneur of The Year 2015 China” by EY

Zhaoke Pharmaceutical (Hefei) Company Limited Ranked Second in 2014 for “the Number of Declared New Drug Application”

2013

Honoured with “Asia’s 200 Best Under a Billion” 2013 by Forbes

2012

Honoured with “Technology Achievement Award 2012” by Hong Kong Awards for Industries

Honoured with “Asia’s 200 Best Under a Billion” 2012 by Forbes

2011

Honoured with “Asia’s 200 Best Under a Billion” 2011 by Forbes

Honoured with “500 Best in Asia Pacific 2011” by Deloitte

2010

Honoured with “500 Best in Asia Pacific 2010” by Deloitte

Honoured with “Hong Kong Outstanding Enterprises 2010” by Economic Digest

Accredited “Asia’s Best Companies 2010 (China) Best Small Cap” ranked 2nd

2009

Honoured with the “Double Excellent Enterprise” by Chinese Government